We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+5.68%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$99.9B
AUM Growth
+$8.57B
Cap. Flow
+$4.38B
Cap. Flow %
4.39%
Top 10 Hldgs %
13.65%
Holding
3,112
New
37
Increased
2,360
Reduced
269
Closed
57

Top Buys

Rank Stock Value
1
HD icon
Home Depot
HD
+$246M
2
XOM icon
ExxonMobil
XOM
+$96.1M
3
AAPL icon
Apple
AAPL
+$62M
4
VZ icon
Verizon
VZ
+$58.6M
5
BA icon
Boeing
BA
+$52.6M

Sector Composition

Rank Sector Weight
1 Technology 14.76%
2 Financials 14.54%
3 Healthcare 12.7%
4 Industrials 11.05%
5 Consumer Discretionary 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GNMX
3026
DELISTED
Aevi Genomic Medicine Inc
GNMX
$82K ﹤0.01%
44,012
ALT icon
3027
Altimmune
ALT
$572M
$81K ﹤0.01%
331
ADVM
3028
DELISTED
Adverum Biotechnologies
ADVM
$77K ﹤0.01%
2,821
FCEL icon
3029
FuelCell Energy
FCEL
$1.54B
$75K ﹤0.01%
151
-120
-44% -$67.7K
TOVX icon
3030
Theriva Biologics
TOVX
$9.49M
$75K ﹤0.01%
13
NH
3031
DELISTED
NantHealth, Inc
NH
$74K ﹤0.01%
987
PRGX
3032
DELISTED
PRGX Global, Inc.
PRGX
$71K ﹤0.01%
11,000
AXSM icon
3033
Axsome Therapeutics
AXSM
$11.8B
$70K ﹤0.01%
17,700
KDMN
3034
DELISTED
Kadmon Holdings, Inc.
KDMN
$67K ﹤0.01%
18,500
APVO icon
3035
Aptevo Therapeutics
APVO
$4.91M
0
AMPE
3036
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$57K ﹤0.01%
235
RCKT icon
3037
Rocket Pharmaceuticals
RCKT
$332M
$56K ﹤0.01%
6,950
CYTR
3038
DELISTED
CytRx Corp
CYTR
$56K ﹤0.01%
21,000
NEON icon
3039
Neonode
NEON
$13.1M
$52K ﹤0.01%
+3,195
New +$52.6K
HBIO icon
3040
Harvard Bioscience
HBIO
$27.4M
$51K ﹤0.01%
1,930
WKHS icon
3041
Workhorse Group
WKHS
$32.4M
$49K ﹤0.01%
6
PN
3042
DELISTED
Patriot National, Inc.
PN
$45K ﹤0.01%
15,800
AGRX
3043
DELISTED
Agile Therapeutics
AGRX
$44K ﹤0.01%
7
TNDM icon
3044
Tandem Diabetes Care
TNDM
$1.23B
$43K ﹤0.01%
3,539
-2,138
-38% -$46.7K
CRDF icon
3045
Cardiff Oncology
CRDF
$60.1M
$41K ﹤0.01%
491
ADPT
3046
DELISTED
Adeptus Health Inc
ADPT
$41K ﹤0.01%
22,300
-34,856
-61% -$196K
AVGR
3047
DELISTED
Avinger, Inc. Common Stock
AVGR
0
ALR
3048
DELISTED
AlerisLife Inc
ALR
$31K ﹤0.01%
1,434
TIO
3049
DELISTED
Tingo Group, Inc. Common Stock
TIO
$31K ﹤0.01%
+26,009
New +$33.8K
ARQL
3050
DELISTED
Arqule Inc
ARQL
$23K ﹤0.01%
21,000

Similar funds

Charles Schwab's Q1 2017 Portfolio in Review

As of Q1 2017, Charles Schwab held 3,112 positions worth $99.9B, up 9.4% from $91.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab deployed $4.38B of net new capital in Q1 2017, opening 37 new positions and adding to 2,360 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 413,073 shares worth $22.5M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Chevron, an estimated $174M trimmed.

  • Charles Schwab's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 413,073 shares worth $22.5M.
  • Charles Schwab added most to Home Depot in Q1 2017, an estimated $246M increase.
  • Charles Schwab's biggest Q1 2017 reduction was Chevron, cutting an estimated $174M.
  • Charles Schwab fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $85.4M.
  • Charles Schwab's ten largest holdings make up 14% of its $99.9B portfolio in Q1 2017.
  • Charles Schwab opened 37 new positions and closed 57 in Q1 2017.
  • Charles Schwab's portfolio value rose 9.4% quarter-over-quarter to $99.9B.

Based on Charles Schwab's 13F filing for Q1 2017, filed 15 May 2017.